B Cell Select News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B cell select. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Cell Select Today - Breaking & Trending Today

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to IPA s Earnings Call for the Third Quarter Fiscal Year 2023. I am Regina, and I will be your host for today s call. ....

San Francisco , United States , Barry Duplantis , Libera Bio , Brad Mcconn , Biostrand Lensai , Ilse Roodink , Ingalls Snyder , International Peer Reviewed , Biggest Health Insurance Companies , Exchange Commission , Health Photo , National Cancer Institute On Unsplash , Journal Cancer Research , Immunoprecise Antibodies Ltd , Immunoprecise Antibodies , Call Transcript March , Third Quarter Fiscal Year , Jennifer Bath , B Cell Select , National Cancer Institute , Trkbt Cell , Health Insurance Companies , Will Make Me Rich , Before Jennifer , Will Mchale ,

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year

Announced Strategic Partnership with Mila to Expand AI Capabilities and Functionality of Antibody Development Platform
Advanced Lead Candidates for COVID-19 PolyTope™ Cocktail Therapy, Preclinical Trials Scheduled to Launch in January 2021
VICTORIA, BC, Dec. 21, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the Company or IPA ) (TSXV: IPA) (OTCQB: IPATF) today announced financial results for the second quarter of its 2021 fiscal year ended October 31, 2020.
Q2 Fiscal 2021 Financial Highlights:

Revenue was $4.8 million for the quarter ended October 31, 2020, an increase of $1.6 million, or 50%, compared to $3.2 million in the same quarter last year.
Adjusted EBITDA was $795,159 for the quarter ended October 31, 2020, an increase of $858,577 compared to ($63,418) in the same quarter last year. ....

British Columbia , Contact Financial Corp , Strategic Ai Partnership , Technology Partnership , Strategic Partnership , National Research Council Canada , Regulation Services Provider , Venture Exchange , Immunoprecise Antibodies Ltd , Functionality Of Antibody Development Platform , Record Quarterly Revenue , Antibody Development , Lead Candidates , Cocktail Therapy , Preclinical Trials Scheduled , Jennifer Bath , Fiscal Year , Talem Therapeutics , Lead Formulation , Preclinical Polytope , Antibody Cocktail Therapy , Genmab Targeting Infectious Disease , Twist Biosciences , Therapeutic Antibody Products , Preclinical Trials , Second Generationb Cell Select ,